Report Overview:
The Global Biosensors Market achieved a valuation of $26.75 Billion in 2022 and is anticipated to exceed $45.95 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 7% during the forecast period from 2024 to 2032.
Key Market Players:
Abbott (US), Roche (Switzerland), Medtronic (Ireland), Bio-Rad Laboratories Inc. (US), DuPont (US), Biosensors...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Russian
Romaian
Portuguese (Brazil)
Greek